Lead the commercial strategic plan for the broad adoption of a blood-based diagnostic to revolutionize the early detection of lung cancer. Recognized expertise in Marketing, Sales, Analytics, Market Development, Medical Affairs, Clinical Research, Publication Strategy, Compliance, Payer Partnerships, and meaningful demonstration projects. • Gained a deep understanding of the market. Amplified sales by identifying, sourcing, and employing targeting data. Surgically focused on highest potential doctors and facilitated execution excellence• Identified and secured nimble, cost-effective, experienced, and exceedingly talented creative partners• Defined and articulated a clear marketing strategy. Designed a compelling sales strategy and exceptional user experience• Optimized sale force deployment• Instituted a systematic hiring process to identify top talent: formalized role descriptions, postings, pre-employment screening, background checks, and a comprehensive salary, bonus, and benefit package• Built a comprehensive training program for sales representatives and client services team; produced and implemented a complete compliance program company wide • Overhauled, simplified, and greatly enhanced the sales platform and IT/hardware• Implemented an effective, highly intuitive CRM throughout the organization

• Rapidly forged beneficial relationships with the most influential KOLs; leveraged these connections to further the rapid adoption of our product for everyone’s benefit -- patients and providers • Sourced scarce biospecimens for clinical trials• Co-published and presented at key scientific meetings• Identified strategic R&D and commercial imperatives to further boost sales including industry-disruptive blood collection devices and techniques and ingenious deployment of mobile phlebotomy assets• Leveraged technology and the ability to think innovatively to conduct the vast majority of a large, prospective clinical trial…remotely

Maximize meaningful bi-directional scientific and clinical exchange. Incorporate external input into company strategy to impact how we develop and commercialize novel oncology diagnostics. • Led the KOL effort. Identified and cultivated internationally and nationally renowned thought leaders o Responsible for aligning with and forging strategic partnerships with medical and scientific thought leaders, clinical influencers, and payers, to ensure a successful commercial launch for two novel prostate cancer tests, and one lung cancer detection test • Devised and guided all medical affairs strategy and tactical activities including scientific advisory boards, clinical advisory boards, major research initiatives and smaller study projects, publication priorities, national and international screening guidelines, medical educational programs, and an effective and compelling speakers’ bureau• Successfully authored and published four (4) peer-reviewed manuscripts. • Invited member, Editorial Board of the Journal of Clinical Trials and Regulatory Affairs.• Invited Speakero American Thoracic Society, 2017o World Conference on Lung Cancer, 2017• Armune BioScience was sold to Exact Sciences (EXAS) in December 2017

Launched my career as a sales representative with Merck & Co., Inc. in rural Louisiana; as result of performance that consistently exceeded expectations, I actively pursued roles of increasing responsibility. Capped my career by shaping and leading Merck’s team of Vaccine Medical Science Liaisons. • Pioneered strategies and tactics for clinical advocacy to enable increased population vaccination coverage. Aligned the CDC and rebranded HPV as cancer prevention. • Orchestrated Marketing Managers, Medical Affairs, and Sales Leaders to develop and accelerate product tactics and resources that address strategic imperatives.o One specific initiative involved a women’s health imperative targeting OBG/GYNs to ensure all patients through 45 years of age were appropriately vaccinated against HPV. Year-end results exceeded plan by 235%. After Merck launched their New Commercial Model, I was charged with leading teams to identify and leverage opportunities to bring providers, payors, employers, and key coalitions together to advance the improvement of patient health outcomes. • Gained a deep understanding of the US Healthcare System across the spectrum of care delivery including acute care, primary care, and wellness/prevention. • Developed expertise in payor incentives (ACOs, P4P) and value-based care. Educated internal stakeholders to market trends impacting Merck business opportunities. • Formed an innovative partnership with a national payer targeting diabetes. Highlighted a range of treatment and prevention options, including health-literate and compelling patient education on both. • Primary Care division finished #1 in the US in sales and share growth. Share for both promoted brands exceeded national objectives due to sales rep access created by the collaboration.• Customer improved quality of care delivered and reduced cost by more than 24%Additional successful experience in Business Intelligence, Sales Leadership, Medical Affairs.